Jessica Sachs
Chief Tech/Sci/R&D Officer bei COGENT BIOSCIENCES, INC.
Vermögen: 8 709 $ am 31.03.2024
Profil
Jessica Sachs is currently the Chief Medical Officer at Cogent Biosciences, Inc. She previously worked as an Associate Director at Genzyme Corp.
from 2010 to 2012 and as a Senior Medical Director-Clinical Research at Takeda Pharmaceutical Co., Ltd.
from 2012 to 2017.
Dr. Sachs holds a doctorate degree from Washington University in St. Louis and an undergraduate degree from Duke University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC.
0,00% | 22.02.2024 | 1 296 ( 0,00% ) | 8 709 $ | 31.03.2024 |
Aktive Positionen von Jessica Sachs
| Unternehmen | Position | Beginn |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01.06.2019 |
Ehemalige bekannte Positionen von Jessica Sachs
| Unternehmen | Position | Ende |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.04.2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Jessica Sachs
| Washington University in St. Louis | Doctorate Degree |
| Duke University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
